US$ 26.18
alternative glp-1 medication A new FDA-approved obesity pill could offer a lower-cost to injectable drugs like Ozempic and Mounjaro. In a major clinical trial, people taking the highest dose lost about 11% of GLP-TRIM - A Natural GLP-1
Description
Of note, in the cost effectiveness study by Lim et al

N Eng J Med

The SUPRPASS-4 trial (262), involving 2002 participants with high-risk cardiovascular profiles followed for up to 104 weeks, showed no difference in 4-MACE events (cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina) with tirzepatide compared to insulin glargine (HR 0.74

LagunasRangel FA

GLP-1 receptor agonists, including liraglutide and semaglutide, demonstrate neuroprotective effects by modulating neuroinflammation and pathways related to neuronal survival [14]
A higher-dose oral (pill) form of semaglutide is also now available for daily use
